Print（PDF/57KB） Jul. 01, 2015 Corporate

Sumitomo Dainippon Pharma announces Changes in Executive Officers and Other Key Positions

Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada) today announced that the following changes in Executive Officers and other key positions will take place effective August 1, 2015:

I. Changes in Executive Officers

Changes in the posts assumed by Executive Officers (effective August 1, 2015)

Post as of August 1, 2015	Current post	Name
Representative Director, President and Chief Executive Officer Executive Director, Drug Development	Representative Director, President and Chief Executive Officer	Masayo Tada
Executive Officer Deputy Executive Director, Drug Development	Executive Officer Executive Director, Drug Development	Nobuyuki Hara

II. Changes in Personnel (effective August 1, 2015)

Drug Development (Division)

Position as of August 1, 2015	Current position	Name
Director, Project Management	Senior Advisor, Drug Development	Teruya Murata
Director, Data Science	Deputy Executive Director, Drug Development Director, Project Management	Hideo Tomiya
Director, Clinical Operation	Group Manager, Clinical Pharmacology Group, Clinical Research	Kenji Shirakura